If you're detecting indications of aging, such as sagging and wrinkles, firmness may be your top priority
NMR Biomed 38:e5313 Provencher SW (1993) Estimation of metabolite concentrations from localized in vivo proton NMR spectra
Welch MD, M.S.P.H., FACPM, ABAARM AgeMD is here to help you feel like yourself again, stronger, clearer, and in control. Health isnt one size fits all
Share your feedback in the comments below
Despite how common GLP-1 use has become, there has been relatively little dermatology-focused research on their cutaneous side effects, with most of the existing literature limited to individual case reports. For the cross-sectional analysis, researchers compared cutaneous adverse events reported in the FDA Adverse Event Reporting System (FAERS) for the GLP-1 receptor agonists semaglutide (Ozempic/ Wegovy, Novo Nordisk), liraglutide, exenatide and dulaglutide (Trulicity, Eli Lilly) with cutaneous adverse event reports for the dipeptidyl peptidase-4 (DPP-IV) inhibitors sitagliptin, saxagliptin, linagliptin and alogliptin
